.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Baxter
Accenture
AstraZeneca
US Army
Cerilliant
Harvard Business School
Fish and Richardson
Medtronic
Argus Health

Generated: November 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019778

« Back to Dashboard
NDA 019778 describes PRINZIDE, which is a drug marketed by Merck and is included in one NDA. Additional details are available on the PRINZIDE profile page.

The generic ingredient in PRINZIDE is hydrochlorothiazide; lisinopril. There are thirty-one drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; lisinopril profile page.

Summary for 019778

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength12.5MG;20MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Feb 16, 1989TE:RLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength25MG;20MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Feb 16, 1989TE:RLD:Yes

Summary for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength12.5MG;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Nov 18, 1993TE:RLD:Yes

Expired Orange Book Patents for NDA: 019778

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck
PRINZIDE
hydrochlorothiazide; lisinopril
TABLET;ORAL019778-003Nov 18, 1993► Subscribe► Subscribe
Merck
PRINZIDE
hydrochlorothiazide; lisinopril
TABLET;ORAL019778-001Feb 16, 1989► Subscribe► Subscribe
Merck
PRINZIDE
hydrochlorothiazide; lisinopril
TABLET;ORAL019778-002Feb 16, 1989► Subscribe► Subscribe
Merck
PRINZIDE
hydrochlorothiazide; lisinopril
TABLET;ORAL019778-002Feb 16, 1989► Subscribe► Subscribe
Merck
PRINZIDE
hydrochlorothiazide; lisinopril
TABLET;ORAL019778-001Feb 16, 1989► Subscribe► Subscribe
Merck
PRINZIDE
hydrochlorothiazide; lisinopril
TABLET;ORAL019778-003Nov 18, 1993► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Moodys
Chubb
McKinsey
Farmers Insurance
McKesson
Colorcon
Medtronic
Federal Trade Commission
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot